Skip to main content
Top
Published in: Radiation Oncology 1/2013

Open Access 01-12-2013 | Research

Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas

Authors: Naofumi Yamatomo, Takaki Iwagami, Itsuro Kato, Shin-Ichiro Masunaga, Yoshinori Sakurai, Soichi Iwai, Mitsuhiro Nakazawa, Koji Ono, Yoshiaki Yura

Published in: Radiation Oncology | Issue 1/2013

Login to get access

Abstract

Background

Boron neutron capture therapy (BNCT) is a selective radiotherapy that is dependent on the accumulation of 10B compound in tumors. Low-intensity ultrasound produces a transient pore on cell membranes, sonoporation, which enables extracellular materials to enter cells. The effect of sonoporation on BNCT was examined in oral squamous cell carcinoma (SCC) xenografts in nude mice.

Materials and methods

Tumor-bearing mice were administrated boronophenylalanine (BPA) or boronocaptate sodium (BSH) intraperitoneally. Two hours later, tumors were subjected to sonoporation using microbubbles followed by neutron irradiation.

Results

The 10B concentration was higher in tumors treated with sonoporation than in untreated tumors, although the difference was not significant in BPA. When tumors in mice that received BPA intraperitoneally were treated with sonoporation followed by exposure to thermal neutrons, tumor volume was markedly reduced and the survival rate was prolonged. Such enhancements by sonoporation were not observed in mice treated with BSH-mediated BNCT.

Conclusions

These results indicate that sonoporation enhances the efficiency of BPA-mediated BNCT for oral SCC. Sonoporation may modulate the microlocalization of BPA and BSH in tumors and increase their intracellular levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009, 31: 748-758. 10.1002/hed.21022CrossRefPubMed Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009, 31: 748-758. 10.1002/hed.21022CrossRefPubMed
2.
go back to reference Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2002, 345: 1890-1900.CrossRef Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2002, 345: 1890-1900.CrossRef
3.
go back to reference Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005, 114: 806-816. 10.1002/ijc.20740CrossRefPubMed Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005, 114: 806-816. 10.1002/ijc.20740CrossRefPubMed
4.
go back to reference Coderre JA, Morris GM: The radiation biology of boron neutron capture therapy. Radiat Res 1999, 151: 1-18. 10.2307/3579742CrossRefPubMed Coderre JA, Morris GM: The radiation biology of boron neutron capture therapy. Radiat Res 1999, 151: 1-18. 10.2307/3579742CrossRefPubMed
5.
go back to reference Barth RF, Coderre JA, Vicente MG, Blue TE: Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 2005, 11: 3987-4002. 10.1158/1078-0432.CCR-05-0035CrossRefPubMed Barth RF, Coderre JA, Vicente MG, Blue TE: Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 2005, 11: 3987-4002. 10.1158/1078-0432.CCR-05-0035CrossRefPubMed
6.
go back to reference Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K: Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353: 1409.CrossRefPubMed Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K: Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353: 1409.CrossRefPubMed
7.
go back to reference Newman CM, Lawrie A, Brisken AF, Cumberland DC: Ultrasound gene therapy: on the road from concept to reality. Echocardiography 2001, 18: 339-347. 10.1046/j.1540-8175.2001.00339.xCrossRefPubMed Newman CM, Lawrie A, Brisken AF, Cumberland DC: Ultrasound gene therapy: on the road from concept to reality. Echocardiography 2001, 18: 339-347. 10.1046/j.1540-8175.2001.00339.xCrossRefPubMed
8.
go back to reference Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG: Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci U S A 1987, 84: 8463-8467. 10.1073/pnas.84.23.8463CrossRefPubMedPubMedCentral Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG: Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci U S A 1987, 84: 8463-8467. 10.1073/pnas.84.23.8463CrossRefPubMedPubMedCentral
9.
go back to reference Escoffre JM, Zeghimi A, Novell A, Bouakaz A: In-vivo gene delivery by sonoporation: recent progress and prospects. Curr Gene Ther 2013, 13: 2-14. 10.2174/156652313804806606CrossRefPubMed Escoffre JM, Zeghimi A, Novell A, Bouakaz A: In-vivo gene delivery by sonoporation: recent progress and prospects. Curr Gene Ther 2013, 13: 2-14. 10.2174/156652313804806606CrossRefPubMed
11.
12.
go back to reference Watanabe Y, Aoi A, Horie S, Tomita N, Mori S, Morikawa H, Matsumura Y, Vassaux G, Kodama T: Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008, 99: 2525-2531. 10.1111/j.1349-7006.2008.00989.xCrossRefPubMed Watanabe Y, Aoi A, Horie S, Tomita N, Mori S, Morikawa H, Matsumura Y, Vassaux G, Kodama T: Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008, 99: 2525-2531. 10.1111/j.1349-7006.2008.00989.xCrossRefPubMed
13.
go back to reference Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 2009, 16: 1146-1153. 10.1038/gt.2009.84CrossRefPubMed Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 2009, 16: 1146-1153. 10.1038/gt.2009.84CrossRefPubMed
14.
go back to reference Kowalczuk L, Boudinet M, el Sanharawi M, Touchard E, Naud MC, Saïed A, Jeanny JC, Behar-Cohen F, Laugier P: In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol 2011, 37: 1814-1827. 10.1016/j.ultrasmedbio.2011.07.010CrossRefPubMed Kowalczuk L, Boudinet M, el Sanharawi M, Touchard E, Naud MC, Saïed A, Jeanny JC, Behar-Cohen F, Laugier P: In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol 2011, 37: 1814-1827. 10.1016/j.ultrasmedbio.2011.07.010CrossRefPubMed
16.
go back to reference Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, Karakagil S, Langholz J, Legemate DA, Martegani A, Llull JB, Pezzoli C, Spinazzi A: Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study. Br J Radiol 2006, 79: 44-51. 10.1259/bjr/23954854CrossRefPubMed Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, Karakagil S, Langholz J, Legemate DA, Martegani A, Llull JB, Pezzoli C, Spinazzi A: Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study. Br J Radiol 2006, 79: 44-51. 10.1259/bjr/23954854CrossRefPubMed
17.
go back to reference Shintani M, Takahashi G, Hamada M, Okunaga S, Iwai S, Yura Y: Effect of ultrasound on herpes simplex virus infection in cell culture. Virology J 2011, 8: 446. 10.1186/1743-422X-8-446CrossRef Shintani M, Takahashi G, Hamada M, Okunaga S, Iwai S, Yura Y: Effect of ultrasound on herpes simplex virus infection in cell culture. Virology J 2011, 8: 446. 10.1186/1743-422X-8-446CrossRef
18.
go back to reference Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB: Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 1994, 30: 643-652. 10.1016/0360-3016(92)90951-DCrossRefPubMed Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB: Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 1994, 30: 643-652. 10.1016/0360-3016(92)90951-DCrossRefPubMed
19.
go back to reference Kamida A, Fujita Y, Kato I, Iwai S, Ono K, Suzuki M, Sakurai Y, Yura Y: Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Int J Radiat Biol 2008, 84: 191-199. 10.1080/09553000801902125CrossRefPubMed Kamida A, Fujita Y, Kato I, Iwai S, Ono K, Suzuki M, Sakurai Y, Yura Y: Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Int J Radiat Biol 2008, 84: 191-199. 10.1080/09553000801902125CrossRefPubMed
20.
go back to reference Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y: Delivery of 10 boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Oral Oncol 2004, 40: 474-482. 10.1016/j.oraloncology.2003.09.018CrossRefPubMed Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y: Delivery of 10 boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Oral Oncol 2004, 40: 474-482. 10.1016/j.oraloncology.2003.09.018CrossRefPubMed
21.
go back to reference Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K, Yoshino K: Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 1989, 2: 388-389.CrossRefPubMed Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K, Yoshino K: Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 1989, 2: 388-389.CrossRefPubMed
22.
go back to reference Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K: Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996, 34: 1081-1086. 10.1016/0360-3016(95)02180-9CrossRefPubMed Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K: Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996, 34: 1081-1086. 10.1016/0360-3016(95)02180-9CrossRefPubMed
23.
go back to reference Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T: Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Jpn J Cancer Res 2002, 93: 1366-1377. 10.1111/j.1349-7006.2002.tb01246.xCrossRefPubMed Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T: Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Jpn J Cancer Res 2002, 93: 1366-1377. 10.1111/j.1349-7006.2002.tb01246.xCrossRefPubMed
24.
go back to reference Detta A, Cruickshank GS: L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res 2009, 69: 2126-2132.CrossRefPubMed Detta A, Cruickshank GS: L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res 2009, 69: 2126-2132.CrossRefPubMed
25.
go back to reference Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J: L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med 2007, 48: 2063-2071. 10.2967/jnumed.107.043620CrossRefPubMed Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J: L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med 2007, 48: 2063-2071. 10.2967/jnumed.107.043620CrossRefPubMed
26.
go back to reference Teissié J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, Rols MP, Golzio M: Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm 2012, 423: 3-6. 10.1016/j.ijpharm.2011.09.038CrossRefPubMed Teissié J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, Rols MP, Golzio M: Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm 2012, 423: 3-6. 10.1016/j.ijpharm.2011.09.038CrossRefPubMed
27.
go back to reference Cemazar M, Skrk J, Mitrovic B, Sersa G: Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol 2000, 73: 195-200.CrossRefPubMed Cemazar M, Skrk J, Mitrovic B, Sersa G: Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol 2000, 73: 195-200.CrossRefPubMed
28.
go back to reference Doi A, Kawabata S, Iida K, Yokoyama K, Kajimoto Y, Kuroiwa T, Shirakawa T, Kirihata M, Kasaoka S, Maruyama K, Kumada H, Sakurai Y, Masunaga S, Ono K, Miyatake S: Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol 2008, 87: 287-294. 10.1007/s11060-008-9522-8CrossRefPubMed Doi A, Kawabata S, Iida K, Yokoyama K, Kajimoto Y, Kuroiwa T, Shirakawa T, Kirihata M, Kasaoka S, Maruyama K, Kumada H, Sakurai Y, Masunaga S, Ono K, Miyatake S: Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol 2008, 87: 287-294. 10.1007/s11060-008-9522-8CrossRefPubMed
29.
go back to reference El-Zaria ME, Nakamura H: New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy. Inorg Chem 2009, 48: 11896-11902. 10.1021/ic902033cCrossRefPubMed El-Zaria ME, Nakamura H: New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy. Inorg Chem 2009, 48: 11896-11902. 10.1021/ic902033cCrossRefPubMed
30.
go back to reference Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000, 407: 249-257. 10.1038/35025220CrossRefPubMed Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000, 407: 249-257. 10.1038/35025220CrossRefPubMed
Metadata
Title
Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas
Authors
Naofumi Yamatomo
Takaki Iwagami
Itsuro Kato
Shin-Ichiro Masunaga
Yoshinori Sakurai
Soichi Iwai
Mitsuhiro Nakazawa
Koji Ono
Yoshiaki Yura
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2013
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-8-280

Other articles of this Issue 1/2013

Radiation Oncology 1/2013 Go to the issue